Detecting chromosomal aberrations associated with cancer using genomic sequencing
AssigneeThe Chinese University of Hong Kong
InventorsYuk-Ming Dennis Lo, Rossa Wai Kwun Chiu, Kwan Chee Chan
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Chinese University of Hong Kong
InventorsYuk-Ming Dennis Lo, Rossa Wai Kwun Chiu, Kwan Chee Chan
Estimating the term…
Methods, systems, and apparatus determine whether a first chromosomal region exhibits a deletion or an amplification associated with cancer in a sample from a subject (e.g., where the sample includes a mixture of cell-free DNA from tumor cells and non-malignant cells. Nucleic acid molecules of the biological sample are sequenced. Respective amounts of a clinically-relevant chromosomal region and of background chromosomal region(s) are determined from results of the sequencing. A parameter derived from these amounts (e.g. a ratio) is compared to one or more cutoff values, thereby determining a classification of whether first chromosomal region exhibits a deletion or an amplification associated with cancer.
A method for analyzing a biological sample from a subject for a chromosomal aberration associated with a tumor in the subject, the method comprising:
Dependencies are inferred from the claim text.